View source for Template to add a clinical trial

{{SI}}

<font color="blue">How to edit trial information:</font> <small> [[Special:UserLogin|Log in]], click on the word [<font color="blue">edit</font>] to the right of the section you would like to edit, type in the appropriate information, click save page at the bottom when you are done. The template is the minimum elements required by the World Health Organization. You can add additional sections.</small> [[Help:How to add a trial to the clinical trial wiki|More help to add a trial here.]]


European Registry on STEMI Patients Transferred for PCI With Upstream Use of Abciximab - EuroTransfer Registry

==Study Acronym <small>(The trial's abbreviation if there is one) </small>==
None reported

Dudek D, Siudak Z, Janzon M, Birkemeyer R, Aldama-Lopez G, Lettieri C, Janus B, Wisniewski A, Berti S, Olivari Z, Rakowski T, Partyka L, Goedicke J, Zmudka K; EUROTRANSFER Registry Investigators.

BACKGROUND: Abciximab is established as adjunct to primary percutaneous coronary intervention (PCI). Based on some smaller studies, ST-segment elevation myocardial infarction (STEMI) networks in various European countries have adopted the start of abciximab before transfer to the catheterization laboratory (cathlab) hospital as part of their routine treatment options. Although a recently published study did not reveal improved clinical outcome when starting abciximab before the cathlab, a potential benefit from such early administration, in particular in the setting of transfer networks, remains unclear and has been the subject of debate.

Patients with ST-Elevation MI

==Study Phase <small>(e.g. Phase I,II,III,IV) [[Study phase|Study Phases are defined here]]</small>==
None reported

Natural History, Cross-Sectional, Defined Population, Prospective Study

== Study Arms and How They Were Treated (Intervention) <small>[[Study arms|(Explanation here)]]</small>==
None reported

== Primary Pre-Specified Endpoint ==
None reported

== Secondary Endpoints ==
None reported

== Inclusion Criteria ==

PATIENTS:

All consecutive STEMI patients >=18years arriving to the Cath Lab hospital (invasive facility center) from transfer.

Transfer with respect to this registry is defined as patients that reach the Cath Lab hospital:

transferred from a surrounding regional community hospitals that the Cath Lab hospital has an established referral pattern with or 
after being picked–up by an ambulance which is equipped/staffed to provide specific medical therapy (like prehospital thrombolysis or upstream abciximab). Usually these have a physician or specifically trained nurse on board.

==Exclusion Criteria==
None reported

==Outcome: Primary endpoint <small>(Report both relative risk reduction and absolute risk reduction as well as number needed to treat if available)</small>==
None reported

==Outcome: Secondary endpoint <small>(Report both relative risk reduction and absolute risk reduction as well as number needed to treat if available)</small>==
None reported

==Outcome: Exploratory endpoints <small>(Report both relative risk reduction and absolute risk reduction as well as number needed to treat if available)</small>==
None reported

==Outcome: Safety endpoints <small>(Report both relative risk and absolute risk as well as number needed to harm if available)</small>==
None reported

==Conclusions of the Investigators <small>(Quote the investigators conclusions here)</small>==
None reported

==Commentary, Discussion and Limitations of the Trial<small> (Anyone can add comments)</small>==
None reported

==Slides==
None reported

==Video Commentary==
None reported

== References [[Help:Adding_References_to_Articles|(How to insert a reference)]]==
None reported

==External sites for further information <small>[[Help:Links|(How to insert links)]]</small>==
None reported

==Detailed information about the trial==
==Ages==
__ years to ___ years 

==Gender <small>(Indicate whether men, women or both were enrolled)</small>==
None reported

==Accepts Healthy Volunteers <small>(Answer yes or no)</small>==
None reported

==Enrollment Period <small>(Study start and end date)</small>==
None reported

==Recruitment Status [[Recruitment status|(explanation)]]==
None reported

==Enrollment <small>(Total number of patients enrolled)</small>==
None reported

==Study Sponsor <small>(e.g. Investigator initiated or company name)</small>==
None reported (this may not have yet been ascertained)

==Source of Data <small>(Where is this data on this page coming from: publication, principal investigator, or co-investigator)</small>==
None reported


The content of the clinical trial wiki consists of fields that have been suggested by the World Health Organization and wwww.clinicaltrials.gov.

[[Category:Clinical trials]]

{{WH}}

{{WS}}